Belly fat becomes harder to lose after the age of 50 due to hormonal changes, sedentary lifestyle, poor nutrition, high ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced new long-term data highlighting the sustained survival benefits of KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 ...